Peripheral blood blast clearance during induction therapy in acute myeloid leukemia [9]

Blood

Volumn 111, Issue 3, 2008, Pages 1746-1747

  Gianfaldoni, Giacomo ^a   Mannelli, Francesco ^b   Bencini, Sara ^b   Leoni, Franco ^b   Baldini, Simone ^b   Bosi, Alberto ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; LETTER; LONG TERM CARE; PERIPHERAL CIRCULATION; PLASMA CLEARANCE; PRIORITY JOURNAL;

EID: 38949208270     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-10-121103     Document Type: Letter

References (5)

1. Elliott MA, Litzow MR, Letendre LL, et al. Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival. Blood. 2007;110:4172-4174.
2. Gianfaldoni G, Mannelli F, Baccini M, et al. Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study. Br J Haematol. 2006;134:54-57.
3. Kern W, Haferlach T, Schoch C, et al. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and a long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood. 2003;101:64-70.
4. San Miguel JF, Vidriales MB, Lopez-Berges C et al. Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to post-induction treatment stratification. Blood. 2001;98:1746-1751.
5. Buccisano F, Maurillo L, Gattei V et al. The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. Leukemia. 2006;20:1783-1789.